ADARx Pharmaceuticals, Inc. financial statements
ADARx Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 3.45M | EODHD |
| Net income | −USD 73.09M | EODHD |
| Cash and equivalents | USD 66.52M | EODHD |
| Total debt | USD 7.74M | EODHD |
ADARx Pharmaceuticals, Inc. financials on 6ix · ADARx Pharmaceuticals, Inc. on 6ix